Literature DB >> 20553862

Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters.

Xiaowan Zheng1, James Polli.   

Abstract

The objective was to identify inhibitor concentrations to efficiently screen and measure inhibition K(i) values of solute carrier (SLC) transporters. The intestinal bile acid transporter and its native substrate taurocholate were used as a model system. Inhibition experiments were conducted using 27 compounds. For each compound, the inhibition constant K(i) was obtained from the comprehensive inhibition profile, and referred as the reference K(i). K(i) values were also estimated from various partial profiles and were compared to the reference K(i). A screening K(i) was estimated from one data point and also compared to the reference K(i). Results indicate that K(i) can be accurately measured using an inhibitor concentration range of only 0-K(i) via five different inhibitor concentrations. Additionally, a screening concentration of 10-fold the substrate affinity K(t) for potent inhibitors (K(i)<20K(t)) and 100-fold K(t) for nonpotent inhibitors (K(i)>20K(t)) provided an accurate K(i) estimation. Results were validated through inhibition studies of two other SLC transporters. In conclusion, experimental conditions to screen and measure accurate transporter inhibition constant K(i) are suggested where a low range of inhibitor concentrations can be used. This approach is advantageous in that minimal compound is needed to perform studies and accommodates compounds with low aqueous solubility. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553862      PMCID: PMC2909451          DOI: 10.1016/j.ejps.2010.05.013

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  17 in total

1.  Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design.

Authors:  Dennis J Murphy
Journal:  Anal Biochem       Date:  2004-04-01       Impact factor: 3.365

2.  Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation.

Authors:  Toshiya Katsura; Ken-Ichi Inui
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

3.  Automated assessment of time-dependent inhibition of human cytochrome P450 enzymes using liquid chromatography-tandem mass spectrometry analysis.

Authors:  Anthony Atkinson; Jane R Kenny; Ken Grime
Journal:  Drug Metab Dispos       Date:  2005-07-27       Impact factor: 3.922

Review 4.  Role of transport proteins in drug discovery and development: a pharmaceutical perspective.

Authors:  A Ayrton; P Morgan
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

5.  Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins.

Authors:  M Jackson; W Song; M Y Liu; L Jin; M Dykes-Hoberg; C I Lin; W J Bowers; H J Federoff; P C Sternweis; J D Rothstein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Enhancement of substrate-gated Cl- currents via rat glutamate transporter EAAT4 by PMA.

Authors:  Hongyu Fang; Yueming Huang; Zhiyi Zuo
Journal:  Am J Physiol Cell Physiol       Date:  2006-05       Impact factor: 4.249

7.  5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.

Authors:  H Han; R L de Vrueh; J K Rhie; K M Covitz; P L Smith; C P Lee; D M Oh; W Sadée; G L Amidon
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

8.  Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1.

Authors:  Yiting Liu; Svetlana Vidensky; Alicia M Ruggiero; Susanne Maier; Harald H Sitte; Jeffrey D Rothstein
Journal:  J Biol Chem       Date:  2007-12-20       Impact factor: 5.157

9.  Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Pharm Res       Date:  2009-05-13       Impact factor: 4.200

10.  Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.

Authors:  Xiaowan Zheng; Sean Ekins; Jean-Pierre Raufman; James E Polli
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

View more
  7 in total

1.  Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

Authors:  Zhongqi Dong; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

2.  Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.

Authors:  Diana Vivian; James E Polli
Journal:  Int J Pharm       Date:  2014-09-16       Impact factor: 5.875

3.  Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.

Authors:  Diana Vivian; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-08-27       Impact factor: 4.384

4.  Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Paul A Dawson; Jean-Pierre Raufman; James E Polli
Journal:  J Pharm Sci       Date:  2014-09-05       Impact factor: 3.534

5.  Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.

Authors:  Zhongqi Dong; Sean Ekins; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-09-16       Impact factor: 4.384

6.  Modelling and targeting mitochondrial protein tyrosine phosphatase 1: a computational approach.

Authors:  Venkataraghavan Ragunathan; K Chithra; C Shivanika; Meenambiga Setti Sudharsan
Journal:  In Silico Pharmacol       Date:  2022-01-17

7.  Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Croton dichogamus Against the HIV-1 Reverse Transcriptase.

Authors:  Ermias Mergia Terefe; Arabinda Ghosh
Journal:  Bioinform Biol Insights       Date:  2022-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.